Clinical Trials Directory

Trials / Completed

CompletedNCT03058718

Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis

Effectiveness of Procalcitonin-Guided Antibiotic Therapy in Acute Exacerbations of Bronchiectasis: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
210 (actual)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To explore effectiveness of procalcitonin-guided antibiotic therapy in acute exacerbations of bronchiectasis, and to explore the clinical value of procalcitonin in bronchiectasis.

Conditions

Interventions

TypeNameDescription
OTHERProcalcitoninThe application of antimicrobial agents is determined by PCT results.
OTHERClinical ExperienceThe application of antimicrobial agents is determined by clinical experience of doctors.

Timeline

Start date
2014-01-01
Primary completion
2016-07-01
Completion
2017-02-01
First posted
2017-02-23
Last updated
2017-02-23

Source: ClinicalTrials.gov record NCT03058718. Inclusion in this directory is not an endorsement.

Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis (NCT03058718) · Clinical Trials Directory